Nitrofurantoin quadruple therapy for H-pylori infection.

被引：0
|
作者：
Graham, DY
Saeed, MA
Hoffman, J
Qureshi, WA
Osato, MS
El-Zimaity, HM
机构：
[1] VAMC, Houston, TX USA
[2] Baylor Coll Med, Houston, TX 77030 USA
来源：
GASTROENTEROLOGY | 2000年 / 118卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(00)80799-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
5679
引用
收藏
页码：A1240 / A1240
页数：1
相关论文
共 50 条
  • [41] H-pylori infection and gastritis
    Elitsur, Y
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1998, 26 (03): : 365 - 366
  • [42] Diagnosis of H-pylori infection
    Sutton, FM
    [J]. INFECTIONS IN MEDICINE, 1998, 15 (05) : 331 - 336
  • [43] The management of H-pylori infection
    Rauws, EAJ
    van der Hulst, RWM
    [J]. BRITISH MEDICAL JOURNAL, 1998, 316 (7126): : 162 - 163
  • [44] Utilization of H2RA in the era of proton pump inhibitor and H-pylori infection.
    Cheung, R
    Alto, P
    Yella, M
    [J]. GASTROENTEROLOGY, 1999, 116 (04) : A51 - A51
  • [45] Effect of H-pylori infection on H+/K+-ATPase mRNA expression in gastric fundic gland mucosa in patients with chronic active gastritis and H-pylori infection.
    Furuta, T
    Baba, S
    Takashima, M
    Hanai, H
    Taneko, E
    [J]. GASTROENTEROLOGY, 1998, 114 (04) : A128 - A128
  • [46] Treatment of H-pylori infection
    deKorwin, JD
    Lozniewski, A
    [J]. PRESSE MEDICALE, 1996, 25 (39): : 1917 - 1922
  • [47] Three months therapy with ranitidine bismuth citrate (RBC) reduces H-pylori-associated gastritis and density of H-pylori but does not cure the infection.
    Graham, DY
    Walsh, JH
    Schubert, TT
    Lanza, FL
    Peura, DA
    Peterson, W
    Riff, DS
    Yardley, J
    Ciociola, AA
    Kong, S
    Wood, D
    Webb, DD
    [J]. GASTROENTEROLOGY, 1996, 110 (04) : A122 - A122
  • [48] Evaluation of the FlexSure(R) HP fingerstick blood test for the detection of H-pylori infection.
    Sadowski, D
    Cohen, H
    Laine, L
    Greenberg, P
    Goldstein, J
    Mihalov, M
    Cutler, AF
    [J]. GASTROENTEROLOGY, 1996, 110 (04) : A246 - A246
  • [49] Interleukin-10 promoter polymorphisms influence risk of chronic H-pylori infection.
    El-Omar, EM
    Wang, CD
    McColl, KE
    Rabkin, CS
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A889 - A889
  • [50] Gatifloxacin-containing sequential therapy for H-pylori infection
    Graham, DY
    Abudayyeh, SA
    El-Zimaity, H
    Hoffman, J
    Opekun, AR
    DeBakey, ME
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S31 - S32
12345